Financials
Financial year 2025
DR. HANS ORLENT from Brugge, company number BE0899300064, closed financial year 2025 with a result of € 219,793 after tax. For that financial year DR. HANS ORLENT recorded a gross margin of € 321,576 and equity of € 999,080. Compared with financial year 2024, the result moved from € 249,707 to € 219,793. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 23, 2026.
€ 999,080
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 219,793
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 455,094
▲ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 114,848 paid out
52 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 10,041
▲ € 7,596 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,221
▼ 42% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 205,133 | € 293,358 | € 371,392 | € 321,576 | ▼ 13% |
| Profit after taxes | € 132,579 | € 190,548 | € 249,707 | € 219,793 | ▼ 12% |
| Equity | € 645,494 | € 705,866 | € 894,136 | € 999,080 | ▲ 12% |
| Total debts | € 241,115 | € 334,518 | € 74,401 | € 60,332 | ▼ 19% |
| Cash | € 671,225 | € 614,811 | € 305,196 | € 455,094 | ▲ 49% |
| Land & buildings | € 124,481 | € 112,695 | € 101,222 | € 94,156 | ▼ 7% |
| Retained profit | € 645,494 | € 705,866 | € 894,136 | € 999,080 | ▲ 12% |
| Dividend | € 220,672 | € 130,176 | € 61,438 | € 114,848 | ▲ 87% |
| Bank debt | € 37,500 | € 22,500 | € 7,500 | € 0 | ▼ 100% |
| Balance sheet total | € 886,609 | € 1,040,384 | € 968,536 | € 1,059,413 | ▲ 9% |
Key figures of DR. HANS ORLENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DR. HANS ORLENT?
What happened at DR. HANS ORLENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 219,793 (▼ 12% vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- Hans Orlent became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 132,579 profit in 2022 to € 219,793 profit in 2025.
Paid € 350,110 in corporate taxes since 2022.
Best year ever: 2024, with € 249,707 profit.
Paid out € 527,133 in dividends to the owners in total.
Management
Behind DR. HANS ORLENT is Hans Orlent.
Directors
According to the 2025 annual accounts
Hans Orlent
Director
since 2008
Establishments
Establishment units
Physical locations of this company
Grote Moerstraat 69
8200 Brugge
Ruddershove 10
8000 Brugge
Active since 8 July 2008
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0899.300.064
- VAT number
- BE 0899.300.064
- Registered office
- Grote Moerstraat 69, 8200 Brugge
- Names & denominations
- DR. HANS ORLENT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 July 2008
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van huisartspraktijken
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering